Joint ventures between health systems, hospitals, independent ASCs, surgeons and other third party groups have become the new face of mergers and acquisitions in the industry. Here are three recent joint venture deals in the ASC industry: 1. Charleston, S.C.-based…
The Latest
Anesthesiologists’ constant presence across the perioperative continuum gives them a uniquely comprehensive view of how operating rooms function. Here are seven anesthesia physicians stepping into executive and clinical leadership positions across health systems and ASCs, as reported by Becker’s in…
The FTC has been active in the healthcare space recently as pressure builds in the debates surrounding prescription drug prices, healthcare consolidation and noncompete agreements for physicians and other clinicians. Here are three recent updates on the FTC: 1. The…
Nashville, Tenn.-based HCA Healthcare is accelerating its push into outpatient care, building on years of aggressive urgent care expansion and a growing slate of freestanding emergency departments as care continues to shift toward lower-cost, more convenient settings. In early February,…
In December, Conshohocken, Pa.-based pharmaceutical services company Cencora said it plans to acquire the majority of the outstanding equity interests it does not already own in OneOncology from TPG for about $3.6 billion, with OneOncology’s affiliated practices and management retaining…
Sarasota (Fla.) Memorial Health Care System plans to open a $12 million outpatient endoscopy and digestive health center next to its Venice hospital. The center will be located in a 54,000-square-foot medical office building under development by Flagship Healthcare Properties.…
Charleston, S.C.-based MUSC Health and Clemson (S.C.) University have broken ground on a 90,000-square-foot medical facility that will include an ASC. Prisma Health Blue Ridge Orthopedics will operate the sports medicine and ASC, according to a Feb. 6 news release…
Specialty drug growth is accelerating, but billing infrastructure has not kept pace. High-cost therapies now represent a growing share of total drug spend and pipeline volume. At the same time, medical benefit claims, prior authorizations, payer policy changes and 340B…
Presented by:
Presenters
David Pope, PharmD
Chief Pharmacy Officer XiFin, Inc.
Mike Fauver
Vice President, Enterprise Solutions XiFin, Inc.
Heather Agostinelli
Vice President, Head of Specialty RCM XiFin, Inc.
Presented by:
Presenters
David Pope, PharmD
Chief Pharmacy Officer XiFin, Inc.
Mike Fauver
Vice President, Enterprise Solutions XiFin, Inc.
Heather Agostinelli
Vice President, Head of Specialty RCM XiFin, Inc.
As ASCs look for ways to boost efficiency without adding staff or cost, leaders are finding the biggest gains come from small operational changes like automated patient outreach and smarter block scheduling. Executives across specialties told Becker’s targeted adjustments in…
